FDA approves genetic test for women with breast cancer.
作者信息
Josefson D
出版信息
BMJ. 1998 Jan 17;316(7126):168.
Abstract
摘要
相似文献
1
FDA approves genetic test for women with breast cancer.美国食品药品监督管理局批准针对乳腺癌女性的基因检测。
BMJ. 1998 Jan 17;316(7126):168.
2
A public health perspective on the control of predictive screening for breast cancer.从公共卫生角度看乳腺癌预测性筛查的控制
Health Matrix Clevel. 1997 Winter;7(1):31-48.
3
Diagnostics. Amid debate, gene-based cancer test approved.诊断学。在争论声中，基于基因的癌症检测方法获得批准。
Science. 2007 Feb 16;315(5814):924. doi: 10.1126/science.315.5814.924.
4
FDA regulation of genetic testing: institutional reluctance and public guardianship.美国食品药品监督管理局对基因检测的监管：机构的抵触与公众的监护
Food Drug Law J. 1998;53(3):555-91.
5
Commercialization of genetic testing services: the FDA, market forces, and biological tarot cards.基因检测服务的商业化：美国食品药品监督管理局、市场力量与生物塔罗牌
Tulane Law Rev. 1997 Mar;71(4):1211-312.
6
The FDA is coming! The FDA is coming!
Mol Diagn. 2001 Sep;6(3):153-4. doi: 10.1054/modi.2001.0060153.
7
FDA approves new drug for specific type of advanced breast cancer.美国食品药品监督管理局批准用于特定类型晚期乳腺癌的新药。
Mayo Clin Womens Healthsource. 2007 Oct;11(10):3.
8
FDA clears new test for rapid identification of breast cancer risk factors.
Expert Rev Mol Diagn. 2002 Jan;2(1):6.
9
How will the FDA impact the laboratory developed test?美国食品药品监督管理局将如何影响实验室研发的检测？
Clin Lab Sci. 2007 Summer;20(3):130-1.
10
Multigene classifiers, prognostic factors, and predictors of breast cancer clinical outcome.多基因分类器、乳腺癌临床结局的预后因素及预测指标。
Adv Anat Pathol. 2009 Jul;16(4):204-15. doi: 10.1097/PAP.0b013e3181a9d4bf.
Zotero 插件